Read the latest from Baszucki Group and its partners.
October 3, 2022 — Three families who have been personally affected by bipolar disorder came together to bring new treatment options to families across the world. BD², Breakthrough Discoveries for thriving with Bipolar Disorder, will serve as a global platform to coordinate science across disciplines and national borders to tackle this complex and still poorly understood disorder.
September 12, 2022 — Google cofounder Sergey Brin; Roblox founder David Baszucki and his wife, author Jan Ellison Baszucki; and Keystone Capital chairman Kent Dauten and his wife Liz Dauten launched a global endeavor called BD² Breakthrough Discoveries for thriving with Bipolar Disorder.
September 12, 2022 — The Baszucki, Dauten, and Brin families joined with the Milken Institute to launch BD²: Breakthrough Discoveries for thriving with Bipolar Disorder. As the largest private investment focused on the study of bipolar disorder, BD² provides an unprecedented opportunity to identify breakthroughs in scientific understanding that create new interventions so that everyone with bipolar disorder can thrive.
September 6, 2022 — The FDA has approved the SAINT Neuromodulation System for the treatment of major depressive disorder in adults who have not seen improvement using antidepressant medications. The Baszuckis are proud to have partnered with Nolan Williams and Magnus Medical to make this timely and personalized treatment accessible to patients with debilitating conditions.